The Nine Year Provision Is Having an Impact on Drug Development Decisions

The nine year provision really affecting sort of drug development decisions, maybe sort of segueing into our conversation about Novartis as well. Are you guys making decisions about not developing drugs in certain ways for certain indications because of that provision? Yes. I mean, I think it's having an impact on how we look at new,. I would say new development programs, of course, in flight development programs, we continue forward.